New strategies to target Bcr-Abl with ATP-competitive and allosteric inhibitors

被引：0
|
作者：
Hantschel, O. [1 ]
机构：
[1] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res ISREC, Lausanne, Switzerland
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：199 / 199
页数：1
相关论文
共 50 条
  • [21] Design and Synthesis of New Heterocyclic Bcr-Abl Inhibitors
    Chen, Yong-Fei
    Ni, Nanting
    Li, Minyong
    Xu, Peng-Fei
    Wang, Binghe
    HETEROCYCLIC COMMUNICATIONS, 2010, 16 (2-3) : 123 - 135
  • [22] ATP-competitive inhibitors of the mitotic kinesin KSP that function via an allosteric mechanism
    Luo, Lusong
    Parrish, Cynthia A.
    Nevins, Neysa
    McNulty, Dean E.
    Chaudhari, Amita M.
    Carson, Jeffery D.
    Sudakin, Valery
    Shaw, Antony N.
    Lehr, Ruth
    Zhao, Huizhen
    Sweitzer, Sharon
    Lad, Latesh
    Wood, Kenneth W.
    Sakowicz, Roman
    Annan, Roland S.
    Huang, Pearl S.
    Jackson, Jeffrey R.
    Dhanak, Dashyant
    Copeland, Robert A.
    Auger, Kurt R.
    NATURE CHEMICAL BIOLOGY, 2007, 3 (11) : 722 - 726
  • [23] Conformation selection by ATP-competitive inhibitors and allosteric communication in ERK2
    Anderson, Jake W.
    Vaisar, David
    Jones, David N.
    Pegram, Laurel M.
    Vigers, Guy P.
    Chen, Huifen
    Moffat, John G.
    Ahn, Natalie G.
    ELIFE, 2024, 12
  • [24] ATP-competitive inhibitors of the mitotic kinesin KSP that function via an allosteric mechanism
    Lusong Luo
    Cynthia A Parrish
    Neysa Nevins
    Dean E McNulty
    Amita M Chaudhari
    Jeffery D Carson
    Valery Sudakin
    Antony N Shaw
    Ruth Lehr
    Huizhen Zhao
    Sharon Sweitzer
    Latesh Lad
    Kenneth W Wood
    Roman Sakowicz
    Roland S Annan
    Pearl S Huang
    Jeffrey R Jackson
    Dashyant Dhanak
    Robert A Copeland
    Kurt R Auger
    Nature Chemical Biology, 2007, 3 : 722 - 726
  • [25] ATP-Competitive Inhibitors of mTOR: An Update
    Schenone, S.
    Brullo, C.
    Musumeci, F.
    Radi, M.
    Botta, M.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (20) : 2995 - 3014
  • [26] Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors
    Jianming Zhang
    Francisco J. Adrián
    Wolfgang Jahnke
    Sandra W. Cowan-Jacob
    Allen G. Li
    Roxana E. Iacob
    Taebo Sim
    John Powers
    Christine Dierks
    Fangxian Sun
    Gui-Rong Guo
    Qiang Ding
    Barun Okram
    Yongmun Choi
    Amy Wojciechowski
    Xianming Deng
    Guoxun Liu
    Gabriele Fendrich
    André Strauss
    Navratna Vajpai
    Stephan Grzesiek
    Tove Tuntland
    Yi Liu
    Badry Bursulaya
    Mohammad Azam
    Paul W. Manley
    John R. Engen
    George Q. Daley
    Markus Warmuth
    Nathanael S. Gray
    Nature, 2010, 463 : 501 - 506
  • [27] Combining the Allosteric ABL1 Tyrosine Kinase Inhibitor ABL001 with ATP-Competitive Inhibitors to Suppress Resistance in Chronic Myeloid Leukemia
    Eide, Christopher A.
    Savage, Samantha L.
    Heinrich, Michael C.
    Schultz, Anna M. Reister
    Tyner, Jeffrey W.
    Tognon, Cristina E.
    Druker, Brian J.
    BLOOD, 2016, 128 (22)
  • [28] Allosteric p97 inhibitors to overcome ATP-competitive inhibitors resistance in anticancer therapy
    Wang, Feng
    Gan, Taiping
    Chou, Tsui-Fen
    FASEB JOURNAL, 2018, 32 (01):
  • [29] Discovery of novel Bcr-Abl inhibitors targeting myristoyl pocket and ATP site
    Dong, Jinyun
    Lu, Wen
    Pan, Xiaoyan
    Su, Ping
    Shi, Yaling
    Wang, Jinfeng
    Zhang, Jie
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (24) : 6876 - 6884
  • [30] Flying under the radar:: the new wave of BCR-ABL inhibitors
    Quintas-Cardama, Alfonso
    Kantarjian, Hagop
    Cortes, Jorge
    NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (10) : 834 - 848
12345